companies / cadrenal-com
Generated UTC · publication cutoff 2026-11-09
Insufficient cited evidence for a two-sentence summary.
verified=2026-05-18 json
| total_raised | 4,400,0004.4M (derived) | derived |
|---|---|---|
| founded | 2022 | |
| hq | Ponte Vedra, Florida | |
| industry | unknown | |
| stage | null |
Cadrenal Therapeutics develops therapies for life-threatening immune and thrombotic conditions, including CAD-1005, a 12-LOX inhibitor for heparin-induced thrombocytopenia. It targets patients with rare cardiovascular and kidney diseases who lack effective options. Unlike existing HIT therapies, CAD-1005 addresses the underlying cause.
No cited completed company acquisition recorded.
Dated disclosures. Customer relationships and classifications are historical; ARR is separate from revenue.
No cited disclosure recorded: named customer, disclosed revenue, ARR, count, B2B / B2C, sector, go-to-market.
No cited valuation with an explicit basis is recorded.
Historical post-money / actual annual or stated TTM revenue. Same currency; economic valuation date within 90 days of revenue period end, inclusive. No FX, ARR, annualized revenue, estimates or projections. Conflicts and ambiguous ties are withheld.
No qualifying pair recorded.
| date | type | amount | lead | src |
|---|---|---|---|---|
| 2025-12-16 | Funding round | 4,400,0004.4M | null | ○ |
Cloudflare, WordPress, Yoast SEO 24.0, jQuery Migrate 3.4.1, Elementor 4.0.9, Elementor Addon Elements 1.0, Cloudflare Bot Management, Cookie Notice 3.0.2, WP Engine, Python, PHP, MySQL
| fact | status | src |
|---|---|---|
| Funding round, $4.4M | attributed | ○ |
| total | derived: Stated total is below the largest recorded round; sum of recorded rounds used | derived |
| existence | self-reported | WEB |
| description | self-reported | WEB |
| date | fact | change | src |
|---|---|---|---|
| 2026-09-28provenance_total: unknown → derived, derived 2026-05-18 | provenance_total | unknown → derived | derived 2026-05-18 |
| 2026-09-28total_raised: 4396329 → 4400000, derived 2026-05-18 | total_raised | 4396329 → 4400000 | derived 2026-05-18 |
| 2026-09-25latest_round: seed, $4.4M, 2025-12-16 → Funding round, $4.4M, 2025-12-16, ○ 2026-05-18 | latest_round | seed, $4.4M, 2025-12-16 → Funding round, $4.4M, 2025-12-16 | ○ 2026-05-18 |
Records begin 2026-09-24. all_changes